Literature DB >> 33594082

Work absence in patients with asthma and/or COPD: a population-based study.

Boudewijn J H Dierick1, Bertine M J Flokstra-de Blok2, Thys van der Molen3, Núria Toledo-Pons4,5, Miguel Román-Rodríguez3,5,6, Borja G Cosío4,5, Joan B Soriano7, Janwillem W H Kocks2, Job F M van Boven3.   

Abstract

Chronic obstructive pulmonary disease (COPD) and asthma impact on work productivity, but their population-based burden and clinical predictors are understudied. In this observational, real-life study, work absence of 14,383 asthma and/or COPD patients present in the MAJORICA cohort (Spain) was compared with the general population. Using multivariable regression, we studied the association of work absence with demographic and clinical characteristics. Patients with asthma and/or COPD had more work absence than the general population (15.2% vs 8.9%, p < 0.0001). Patients with asthma had more often periods of work absence compared to patients with COPD (16.0% vs 12.8%, p < 0.0001). The number of days absent were, however, less in asthma than in COPD (median: 15 days [IQR: 5-51] vs 39 days [IQR: 13-134], p < 0.001). Patients with asthma-COPD overlap were in between (14.5% with absence; median: 27 days [IQR: 10-82]). Comorbid anxiety, allergic rhinitis, and sleep apnoea were independently associated with more work absence.

Entities:  

Year:  2021        PMID: 33594082     DOI: 10.1038/s41533-021-00217-z

Source DB:  PubMed          Journal:  NPJ Prim Care Respir Med        ISSN: 2055-1010            Impact factor:   2.871


  4 in total

1.  Can electronic monitoring with a digital smart spacer support personalised medication adherence and inhaler technique education in patients with asthma?: Protocol of the randomised controlled OUTERSPACE trial.

Authors:  Boudewijn H J Dierick; Maria Achterbosch; Sandra Been-Buck; Titia Klemmeier; Susanne J van de Hei; Paul Hagedoorn; Huib A M Kerstjens; Janwillem W H Kocks; Job F M van Boven
Journal:  BMJ Open       Date:  2022-06-13       Impact factor: 3.006

2.  Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma.

Authors:  Leanne Kaye; Vy Vuong; Meredith A Barrett; Elroy Boers; Theresa Guilbert
Journal:  NPJ Prim Care Respir Med       Date:  2022-09-02       Impact factor: 3.289

3.  Common Mental Disorders, Functional Limitation and Diet Quality Trends and Related Factors among COPD Patients in Spain, 2006-2017: Evidence from Spanish National Health Surveys.

Authors:  Silvia Portero de la Cruz; Jesús Cebrino
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

4.  Characteristics and Determinants of the Presence of Respiratory Symptoms among Sewage Workers in Malaysia.

Authors:  Kamarulzaman Muzaini; Siti Munira Yasin; Zaliha Ismail; Ahmad Razali Ishak
Journal:  J Environ Public Health       Date:  2022-03-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.